The present study was carried out to evaluate the antidiabetic and anti hyperlipidemic activity of Ephedra in streptozotocin induced diabetic rats. 40 male BALB/cArc Wistar rats aged eight to ten weeks (200 to 250 g) were randomly divided into 4 groups. No statistically significant difference was observed in body weight between the healthy group (A) and other groups before the trial. There was a significant differences between the diabetic and healthy groups. STZ injection was done in groups B and D, the mean blood glucose level increased notably in groups B and D on the 3rd day in comparison with other groups. The result shows that Ephedra extract can be used to control diabetes and absence of acute toxicity may offer a new hope to the diabetics in future.
Shojaie Mohammad, Hosseinpoor Masoumeh*, Jelodar Gholamali and Tavanaie Hoda
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : April 18, 2019